 | Up a level |
Abdelhak, Ahmed; Benkert, Pascal; Schaedelin, Sabine; Boscardin, W John; Cordano, Christian; Oechtering, Johanna; Ananth, Kirtana; Granziera, Cristina; Melie-Garcia, Lester; Montes, Shivany Condor; Beaudry-Richard, Alexandra; Achtnichts, Lutz; Oertel, Frederike C; Lalive, Patrice H; Leppert, David; Müller, Stefanie; Henry, Roland G; Pot, Caroline; Matthias, Amandine; Salmen, Anke; ... (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA neurology, 80(12), pp. 1317-1325. American Medical Association 10.1001/jamaneurol.2023.3997
Gold, Ralf; Piani-Meier, Daniela; Kappos, Ludwig; Bar-Or, Amit; Vermersch, Patrick; Giovannoni, Gavin; Fox, Robert J; Arnold, Douglas L; Benedict, Ralph H B; Penner, Iris-Katharina; Rouyrre, Nicolas; Kilaru, Ajay; Karlsson, Göril; Ritter, Shannon; Dahlke, Frank; Hach, Thomas; Cree, Bruce A C (2022). Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study. Journal of neurology, 269(9), pp. 5093-5104. Springer 10.1007/s00415-022-11166-z
